CRISPR Modified Stem Cell Therapy for Type 1 Diabetes
13 May 2022 | Canada
Researchers have received $1 million from Canada's Stem Cell Network to conduct research and a clinical trial for one of the world's first genetically engineered cell replacement therapies for type 1 diabetes. The researchers say the study is an important step toward developing a potential functional cure for type 1 diabetes.
You are not logged in. For existing users, please login to learn more about this premium content. For new users, please register with idtechex.com or use the links below for more details about premium content from IDTechEx.
Subscription Benefits
A subscription from IDTechEx allows you to access our full body of research content on emerging technologies, including market, technology and company data, alongside direct engagement with our expert analysts.
Subscription content includes:
Subscription content includes:
- Market research reports
- Forecasts
- Premium articles
- Company profiles
- Industry digests
- Webinars
- Innovation maps
- Event summaries and write-ups
